DURHAM,
N.C., Sept. 25, 2024 /PRNewswire/
-- MedPharm, a global topical and transdermal Contract
Development and Manufacturing Organization ("CDMO"), today
announced Mr. Eric Evans will join
its Board of Directors. With more than 30 years of experience, Mr.
Evans has held senior financial leadership roles at companies
across the pharmaceutical and contract services industries,
including holding the position of Chief Financial Officer at the
following companies: Alcami Corporation, TriPharm Services, Avista
Pharma, Mayne Pharma, AAIPharma Services, and Patheon. Earlier in
his career, Mr. Evans held executive finance positions at Novartis
and Sandoz.
"Eric's track record of providing leadership in financial and
operational strategies as CFO of multiple high-growth, successful
private equity-backed organizations is truly impressive," commented
Patrick Walsh, Executive Chairman at
MedPharm. "I am delighted to be working with him again."
On his appointment to MedPharm's Board of Directors, Eric
commented, "MedPharm has a well-documented history of providing
reliable drug delivery services to the global pharma community and
with its recent merger with Tergus Pharma, it has set the stage for
an exciting next chapter of growth."
About MedPharm
MedPharm is an end-to-end contract
service provider of topical and transepithelial products supporting
early phase research, formulation development and in vitro testing
services in addition to both clinical and commercial manufacturing.
With MedPharm's recent merger with Tergus Pharma, MedPharm enhanced
its capabilities, transforming the business into a truly
differentiated CDMO of scale with superior end-to-end capabilities
from drug development & formulation to large batch commercial
manufacturing and distribution. For more than 25 years, MedPharm
has specialized in reducing risk through its unique,
industry-leading in vitro testing and research biology models and
is a global leader in product development for dermal/transdermal,
lung and nasal, mucosal membrane, ungual, otic and ophthalmic
delivery. MedPharm has locations in the United Kingdom and United States, including a new 97,000 sq. ft.
state-of-the-art manufacturing facility in Durham, NC. For more information,
visit medpharm.com.
About Ampersand Capital Partners
Ampersand
Capital Partners, founded in 1988, is a middle-market private
equity firm with $3 billion of assets
under management, dedicated to growth-oriented investments in the
healthcare sector. With offices in Boston, MA, and Amsterdam, Netherlands, Ampersand leverages a
unique blend of private equity and operating experience to build
value and drive long-term performance alongside its portfolio
company management teams. Ampersand has helped build numerous
market-leading companies across each of the firm's core healthcare
sectors. For additional information,
visit Ampersandcapital.com or follow us
on LinkedIn.
About Bourne Partners Strategic Capital
("BPSC")
Headquartered in Charlotte, N.C., Bourne Partners Strategic
Capital is a private equity and growth equity investment firm
focused exclusively on the pharmaceutical, pharma services and
consumer healthcare sectors. As owners and operators with over 20
years of experience, BPSC has investment, strategic and operational
experience in companies ranging from $5M to $3B in
equity value and seeks to align and partner with management teams
and other owners in these sectors to grow their businesses. BPSC is
a related company of Bourne Partners, which offers investment
banking and advisory services in the same key focus areas. For more
information, please visit bourne-partners.com.
About Great Point Partners
Great Point Partners,
founded in 2003 and based in Greenwich,
CT, manages over $1.9B of
capital in its private funds and public life sciences equity
strategy (BioMedical Value Fund). The private equity funds invest
across all sectors of the health care industry with a particular
emphasis on biopharmaceutical services and supplies, alternate site
care, medical device contract manufacturing and information
technology enabled businesses. The firm pursues a proactive and
proprietary approach to sourcing investments and tuck-in
acquisitions for its portfolio companies. For additional
information, visit gppfunds.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/medpharm-announces-board-expansion-with-appointment-of-industry-veteran-eric-evans-302258472.html
SOURCE MedPharm